Involvement of aberrant DNA methylation on reduced expression of lysophosphatidic acid receptor-1 gene in rat tumor cell lines

Biochemical and Biophysical Research Communications

Volumn 349, Issue 3, 2006, Pages 1151-1155

  Tsujiuchi, Toshifumi ^a   Shimizu, Kyoko ^a   Onishi, Mariko ^a   Sugata, Eriko ^a   Fujii, Hiromasa ^b   Mori, Toshio ^b   Honoki, Kanya ^b   Fukushima, Nobuyuki ^a  

^a Faculty of Science and Engineering   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

DNA methylation; Gene silencing; Lysophosphatidic acid receptor 1; Rat

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; DNA; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN; CANCER CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA METHYLATION; LIVER; LIVER CELL CARCINOMA; MALE; NEUROBLASTOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STRESS FIBER;

ANIMALS; BRAIN; CELL LINE, TUMOR; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; LIVER; RATS; RECEPTORS, LYSOPHOSPHATIDIC ACID; RNA, MESSENGER;

EID: 33748625994     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.08.159     Document Type: Article

References (32)

1. Contos J.J.A., Ishii I., and Chun J. Lysophosphatidic acid receptors. Mol. Pharmacol. 58 (2000) 1188-1196
2. Furui T., LaPushin R., Mao M., et al. Overexpression of Edg-2/vzg-1 Induces apoptosis and anoikis in ovarian cancer cells in a lysophatidic acid-independent manner. Clin. Cancer Res. 5 (1999) 4308-4318
3. Goetzl E.J., Dolezalova H., Kong Y., et al. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. Cancer Res. 59 (1999) 5370-5375
4. Contos J.J.A., Fukushima N., Weiner J.A., et al. Requirement for the lpA1 lysophosohatidic acid receptor gene in normal suckling behavior. Proc. Natl. Acad. Sci. USA 97 (2000) 13383-13389
5. Contos J.J.A., Ishii I., Fukushima N., et al. Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysopfosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2). Mol. Cell Biol. 22 (2002) 6921-6929
6. Fang X., Schummer M., Mao M., et al. Lysophosphatidic acid is a bioactive mediator in ovarian cancer. Biochim. Biophys. Acta 1582 (2002) 257-264
7. Fujita T., Miyamoto S., Onoyama I., et al. Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer. Cancer Lett. 192 (2003) 161-169
8. An S., Bleu T., Halmark O.G., and Goetzl E.J. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J. Biol. Chem. 273 (1998) 7906-7910
9. Bandoh K., Aoki J., Hosono H., et al. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J. Biol. Chem. 274 (1999) 27776-27785
10. Noguchi K., Ishii S., and Shimizu T. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J. Biol. Chem. 278 (2003) 25600-25606
11. Lee C.W., Rivera R., Gardell S., Dubin A.E., and Chun J. GPR92 as a new G12/13 and Gq coupled lysophosphatidic acid receptor that increases cAMP: LPA5. J. Biol. Chem. 281 (2006) 23589-23597
12. Shida D., Watanabe T., Aoki J., et al. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer. Lab. Invest. 84 (2004) 1352-1362
13. Schulte K.M., Beyer A., Kohrer K., et al. Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: over-expression of the high-affinity receptor edg4 in differentiated thyroid cancer. Int. J. Cancer 92 (2001) 249-256
14. Meehan R., Lewis J., and Cross S. Transcriptional repression by methylation of CpG. Cell Sci. Suppl. 16 (1992) 9-14
15. Zingg J.M., and Jones P.A. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis 18 (1997) 869-882
16. Jones P.A., and Laird P.W. Cancer epigenetics comes of age. Nat. Genet. 21 (1999) 163-167
17. Baylin S.B., and Herman J.G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16 (2000) 168-174
18. Chan M.F., Liang G., and Jones P.A. Relationship between transcription and DNA methylation. Curr. Top. Microbiol. Immunol. 249 (2000) 75-86
19. Adams R.L., Davis T., Rinaldi A., and Eason R. CpG deficiency, dinucleotide distributions and nucleosome positioning. Eur. J. Biochem. 165 (1987) 107-115
20. Keshet I., Lieman W.J., and Cedar H. DNA methylation affects the formation of active chromatin. Cell 44 (1986) 535-543
21. Jones P.A. DNA methylation and cancer. Oncogene 21 (2002) 5358-5360
22. Jones P.A., and Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3 (2002) 415-428
23. Costello J.F., Fruhwald M.C., Smiraglia D.J., et al. Aberrant CpG-island methylation has non-random and tumor-type-specific patterns. Nat. Genet. 24 (2000) 132-138
24. Esteller M., Corn P.G., Baylin S.B., and Herman J.G. A gene hypermethylation profile of human cancer. Cancer Res. 61 (2001) 3225-3229
25. Tsujiuchi T., Mori T., Amanuma T., et al. Establishment and characterization of a rat lung adenocarcinoma cell line with low malignant potential. Cancer Lett. 217 (2005) 97-103
26. Honoki K., Tsujiuchi T., Sasaki Y., et al. Differential expression of cytokines in rat osteosarcoma and malignat fibrous histiocytoma cell lines induced by 4-(hydroxyamino) quino-line-1-oxide. Mol. Carcinog. 33 (2002) 81-87
27. A1/edy-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid. Proc. Natl. Acad. Sci. USA 95 (1998) 6151-6156
28. INK4a gene and methylation pattern of CpG sites in the promoter region in rat tumor cell lines. Mol. Carcinog. 39 (2004) 10-14
29. Zhu W.-G., Dai Z., Ding H., et al. Increased expression of unmethylated CDK2D by 5-aza-2′-deoxycytidine in human lung cancer cells. Oncogene 20 (2001) 7787-7796
30. Guler G., Ilipoulos D., Han S.Y., et al. Hepermethylation patterns in the Fhit regulatory region are tissue specific. Mol. Carcinog. 43 (2005) 175-181
31. Shida D., Kitayama J., Yamaguchi H., et al. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res. 63 (2003) 1706-1711
32. Radeff-Huang J., Seasholtz T.M., Matteo R.G., and Brown J.H. G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival. J. Cell. Biochem. 92 (2004) 949-966